Literature DB >> 25863193

Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.

Richard A Becker1, Gerald T Ankley2, Stephen W Edwards3, Sean W Kennedy4, Igor Linkov5, Bette Meek6, Magdalini Sachana7, Helmut Segner8, Bart Van Der Burg9, Daniel L Villeneuve2, Haruna Watanabe10, Tara S Barton-Maclaren11.   

Abstract

Systematic consideration of scientific support is a critical element in developing and, ultimately, using adverse outcome pathways (AOPs) for various regulatory applications. Though weight of evidence (WoE) analysis has been proposed as a basis for assessment of the maturity and level of confidence in an AOP, methodologies and tools are still being formalized. The Organization for Economic Co-operation and Development (OECD) Users' Handbook Supplement to the Guidance Document for Developing and Assessing AOPs (OECD 2014a; hereafter referred to as the OECD AOP Handbook) provides tailored Bradford-Hill (BH) considerations for systematic assessment of confidence in a given AOP. These considerations include (1) biological plausibility and (2) empirical support (dose-response, temporality, and incidence) for Key Event Relationships (KERs), and (3) essentiality of key events (KEs). Here, we test the application of these tailored BH considerations and the guidance outlined in the OECD AOP Handbook using a number of case examples to increase experience in more transparently documenting rationales for assigned levels of confidence to KEs and KERs, and to promote consistency in evaluation within and across AOPs. The major lessons learned from experience are documented, and taken together with the case examples, should contribute to better common understanding of the nature and form of documentation required to increase confidence in the application of AOPs for specific uses. Based on the tailored BH considerations and defining questions, a prototype quantitative model for assessing the WoE of an AOP using tools of multi-criteria decision analysis (MCDA) is described. The applicability of the approach is also demonstrated using the case example aromatase inhibition leading to reproductive dysfunction in fish. Following the acquisition of additional experience in the development and assessment of AOPs, further refinement of parameterization of the model through expert elicitation is recommended. Overall, the application of quantitative WoE approaches hold promise to enhance the rigor, transparency and reproducibility for AOP WoE determinations and may play an important role in delineating areas where research would have the greatest impact on improving the overall confidence in the AOP.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse outcome pathway; Bradford-Hill considerations; Mode of action; Weight of evidence

Mesh:

Substances:

Year:  2015        PMID: 25863193     DOI: 10.1016/j.yrtph.2015.04.004

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  59 in total

Review 1.  Accelerating Adverse Outcome Pathway Development Using Publicly Available Data Sources.

Authors:  Noffisat O Oki; Mark D Nelms; Shannon M Bell; Holly M Mortensen; Stephen W Edwards
Journal:  Curr Environ Health Rep       Date:  2016-03

2.  Linking Mitochondrial Dysfunction to Organismal and Population Health in the Context of Environmental Pollutants: Progress and Considerations for Mitochondrial Adverse Outcome Pathways.

Authors:  David A Dreier; Danielle F Mello; Joel N Meyer; Christopher J Martyniuk
Journal:  Environ Toxicol Chem       Date:  2019-08       Impact factor: 3.742

Review 3.  Practical approaches to adverse outcome pathway development and weight-of-evidence evaluation as illustrated by ecotoxicological case studies.

Authors:  Kellie A Fay; Daniel L Villeneuve; Carlie A LaLone; You Song; Knut Erik Tollefsen; Gerald T Ankley
Journal:  Environ Toxicol Chem       Date:  2017-03-31       Impact factor: 3.742

Review 4.  Ecdysone Receptor Agonism Leading to Lethal Molting Disruption in Arthropods: Review and Adverse Outcome Pathway Development.

Authors:  You Song; Daniel L Villeneuve; Kenji Toyota; Taisen Iguchi; Knut Erik Tollefsen
Journal:  Environ Sci Technol       Date:  2017-04-10       Impact factor: 9.028

5.  Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.

Authors:  Katherine K Coady; Ronald C Biever; Nancy D Denslow; Melanie Gross; Patrick D Guiney; Henrik Holbech; Natalie K Karouna-Renier; Ioanna Katsiadaki; Hank Krueger; Steven L Levine; Gerd Maack; Mike Williams; Jeffrey C Wolf; Gerald T Ankley
Journal:  Integr Environ Assess Manag       Date:  2017-01-18       Impact factor: 2.992

6.  Advancing the adverse outcome pathway framework-An international horizon scanning approach.

Authors:  Carlie A LaLone; Gerald T Ankley; Scott E Belanger; Michelle R Embry; Geoff Hodges; Dries Knapen; Sharon Munn; Edward J Perkins; Murray A Rudd; Daniel L Villeneuve; Maurice Whelan; Catherine Willett; Xiaowei Zhang; Markus Hecker
Journal:  Environ Toxicol Chem       Date:  2017-06       Impact factor: 3.742

7.  Adverse outcome pathway networks II: Network analytics.

Authors:  Daniel L Villeneuve; Michelle M Angrish; Marie C Fortin; Ioanna Katsiadaki; Marc Leonard; Luigi Margiotta-Casaluci; Sharon Munn; Jason M O'Brien; Nathan L Pollesch; L Cody Smith; Xiaowei Zhang; Dries Knapen
Journal:  Environ Toxicol Chem       Date:  2018-05-07       Impact factor: 3.742

8.  Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report.

Authors:  Amy J Clippinger; David Allen; Annie M Jarabek; Marco Corvaro; Marianna Gaça; Sean Gehen; Jon A Hotchkiss; Grace Patlewicz; Jodie Melbourne; Paul Hinderliter; Miyoung Yoon; Dongeun Huh; Anna Lowit; Barbara Buckley; Michael Bartels; Kelly BéruBé; Daniel M Wilson; Ian Indans; Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2017-12-22       Impact factor: 3.500

9.  The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology.

Authors:  Gerald T Ankley; Stephen W Edwards
Journal:  Curr Opin Toxicol       Date:  2018-06-01

Review 10.  Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Authors:  Min-Ae Song; Neal L Benowitz; Micah Berman; Theodore M Brasky; K Michael Cummings; Dorothy K Hatsukami; Catalin Marian; Richard O'Connor; Vaughan W Rees; Casper Woroszylo; Peter G Shields
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.